Despite advancements in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma (MCL), resistance and recurrence occur frequently and mutations might develop during treatment. Given the diverse range of treatment side effects, it is critical that hematology/oncology clinicians know how to select appropriate medications for each patient as well as have insight about optimization of drug sequencing, used alone or in combination, and the issue of intolerance. Clinicians must possess a comprehensive understanding of these challenges and implement specific management of drug-related toxicities using a shared decision-making and multidisciplinary approach. In this CE Concepts Grand Rounds series, expert faculty will explore the latest clinical trial data on novel treatment options for patients with resistant/recurrent (R/R) CLL/SLL, utilization of an evidence-based approach for personalizing treatment for patients with R/R MCL, and prioritization of patient adherence and active engagement through development of multidisciplinary frameworks to oversee and address adverse events. The faculty will also provide insight through case-based discussions.
- Provider:Creative Educational Concepts, Inc.
- Activity Link: https://www.ceconcepts.com/activity/advancements-in-the-management-of-relapsed-refractory-b-cell-malignancies-integrating-recent-data-into-practice-to-improve-outcomes/
- Start Date: 2025-02-10 06:00:00
- End Date: 2025-02-10 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Lilly (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Internal Medicine